Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
Center for Health Care Services
mi
from
San Antonio, TX
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Center for Health Care Services
mi
from
San Antonio, TX
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
Frontier Institute-Research Department for Spokane Mental Health
mi
from
Spokane, WA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Frontier Institute-Research Department for Spokane Mental Health
mi
from
Spokane, WA
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
San Fernando Mental Health Center
mi
from
Granada Hills, CA
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
San Fernando Mental Health Center
mi
from
Granada Hills, CA
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
The University of California Irvine
mi
from
Orange, CA
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
The University of California Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
Yale University
mi
from
New Haven, CT
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
University of Miami Department of Psychiatry
mi
from
Miami, FL
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
University of Miami Department of Psychiatry
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
Med College of Georgia
mi
from
Augusta, GA
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
Med College of Georgia
mi
from
Augusta, GA
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
Northwestern University
mi
from
Chicago, IL
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
Rush University Psychiatric Clinical Research Center
mi
from
Chicago, IL
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
Rush University Psychiatric Clinical Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
Indiana University
mi
from
Indianapolis, IN
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
Univ of Minnesota
mi
from
Minneapolis, MN
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
University of Missouri
mi
from
Columbia, MO
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
Columbia University
mi
from
New York, NY
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research
mi
from
New York, NY
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
Duke University Medical Center
mi
from
Butner, NC
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
Duke University Medical Center
mi
from
Butner, NC
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
UT Southwestern Medical Center
mi
from
Dallas, TX
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated:  10/3/2012
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
Status: Enrolling
Updated: 10/3/2012
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Aripiprazole for Co-Morbid Schizophrenia and Cocaine Dependence
A Double-Blind, Controlled Study of Aripiprazole Versus Perphenazine in Co-Morbid Schizophrenia and Cocaine Dependence
Status: Enrolling
Updated:  10/12/2012
Department of Veterans Affairs Eastern Colorado Healthcare System
mi
from
Denver, CO
Aripiprazole for Co-Morbid Schizophrenia and Cocaine Dependence
A Double-Blind, Controlled Study of Aripiprazole Versus Perphenazine in Co-Morbid Schizophrenia and Cocaine Dependence
Status: Enrolling
Updated: 10/12/2012
Department of Veterans Affairs Eastern Colorado Healthcare System
mi
from
Denver, CO
Click here to add this to my saved trials
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Status: Enrolling
Updated:  10/16/2012
University of California-Davis
mi
from
Sacramento, CA
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Status: Enrolling
Updated: 10/16/2012
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Status: Enrolling
Updated:  10/16/2012
University of California, San Francisco
mi
from
San Francisco, CA
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Status: Enrolling
Updated: 10/16/2012
University of California, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis
Recovery After an Initial Schizophrenia Episode (RAISE): The RAISE Connection Program
Status: Enrolling
Updated:  10/26/2012
University of Maryland Medical Center, Carruthers Clinic
mi
from
Baltimore, MD
Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis
Recovery After an Initial Schizophrenia Episode (RAISE): The RAISE Connection Program
Status: Enrolling
Updated: 10/26/2012
University of Maryland Medical Center, Carruthers Clinic
mi
from
Baltimore, MD
Click here to add this to my saved trials
Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis
Recovery After an Initial Schizophrenia Episode (RAISE): The RAISE Connection Program
Status: Enrolling
Updated:  10/26/2012
Washington Heights Community Service Clinic
mi
from
New York, NY
Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis
Recovery After an Initial Schizophrenia Episode (RAISE): The RAISE Connection Program
Status: Enrolling
Updated: 10/26/2012
Washington Heights Community Service Clinic
mi
from
New York, NY
Click here to add this to my saved trials
A Study To Assess Effects Of PF-04958242 On Bold Functional Magnetic Resonance Imaging During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects
Subject And Investigator-Blinded, Sponsor-Open, Randomized, Single-Dose, Placebo-Controlled, Parallel Group Study To Assess Effects Of PF-04958242 On Bold Functional MRI During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects
Status: Enrolling
Updated:  10/31/2012
Pfizer Investigational Site
mi
from
Bridgeport, CT
A Study To Assess Effects Of PF-04958242 On Bold Functional Magnetic Resonance Imaging During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects
Subject And Investigator-Blinded, Sponsor-Open, Randomized, Single-Dose, Placebo-Controlled, Parallel Group Study To Assess Effects Of PF-04958242 On Bold Functional MRI During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects
Status: Enrolling
Updated: 10/31/2012
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Dothan, AL
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Dothan, AL
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Anaheim, CA
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Colton, CA
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Colton, CA
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Costa Mesa, CA
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Downey, CA
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Downey, CA
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Murrieta, CA
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Murrieta, CA
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
San Diego, CA
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Aurora, CO
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Hartford, CT
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Hartford, CT
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Washington,
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Orange City, FL
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Orange City, FL
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Orlando, FL
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Atlanta, GA
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Smyrna, GA
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Smyrna, GA
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Coeur D'Alene, ID
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Coeur D'Alene, ID
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Wichita, KA
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Rochester, NY
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Chapel Hill, NC
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Cleveland, OH
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Memphis, TN
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Bothell, WA
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM2)
An 8-week, Placebo-controlled, Double-blind, Randomized, Fixed-dose Efficacy and Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Bothell, WA
Click here to add this to my saved trials
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897 AM2 EXT)
A 26-week, Multi-center, Open-label, Flexible Dose, Long-term Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated:  11/7/2012
Clinical Research Facility
mi
from
Dothan, AL
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897 AM2 EXT)
A 26-week, Multi-center, Open-label, Flexible Dose, Long-term Safety Trial of Asenapine in Adolescent Subjects With Schizophrenia
Status: Enrolling
Updated: 11/7/2012
Clinical Research Facility
mi
from
Dothan, AL
Click here to add this to my saved trials